Switching from Buy-Side FI Research to RX Advisory

I recently accepted an offer at a boutique asset management firm (~$500B) within their high-yield and leveraged loans group for next summer. Moving forward (full-time), I am interested in transitioning to either RX advisory or private credit roles (mezz funds, hybrid-value, stressed/distressed lending, etc.).

How easy/difficult would it be to make this move? For those who have done so, are there any lessons that you learned along the way that you would be willing to share?

Thank you in advance.

1 Comments
 

Dolorem eligendi tempore quisquam non tempora deserunt molestias. Quia quis consequatur quae eveniet corporis. Aut illum itaque mollitia non mollitia et. Dolores possimus sequi fuga id nihil eveniet.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”